✦ LIBER ✦

A Phase I Trial: Dose Escalation of Melphalan in the “BEAM” Regimen Using Amifostine Cytoprotection

✍ Scribed by Gordon L. Phillips II; Steven H. Bernstein; Jane L. Liesveld; Camille N. Abboud; Michael W. Becker; Louis S. Constine; J.J. Ifthikharuddin; John E. Loughner; Laurie A. Milner; David H. Vesole; Jonathan W. Friedberg

Book ID: 116281951
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 319 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.11.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study for poor-prognosis lymphom

Phase I study for poor-prognosis lymphoma: Augmentation of the “BEAM” regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation — a preliminary report

✍ G.L. Phillips II; C.N. Abboud; S.H. Bernstein; J.W. Friedberg; J.J. Ifthikharudd 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Prospective randomised trial of amifosti

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

✍ Spencer, A; Horvath, N; Gibson, J; Prince, H M; Herrmann, R; Bashford, J; Joske, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 145 KB

A Phase I Dose-Escalation Trial of High-

A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Normal Renal Function

✍ Abidi, Muneer H.; Agarwal, Rishi; Tageja, Nishant; Ayash, Lois; Deol, Abhinav; A 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 152 KB

A phase I dose escalation trial of yttri

A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma

✍ Frances A. Shepherd; Lorne E. Rotstein; Sylvain Houle; Tsui-Chun K. Yip; Karen P 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 2 views

First results of a phase I/II dose escal

First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy

✍ José S.A Belderbos; Katrien De Jaeger; Wilma D Heemsbergen; Yvette Seppenwoolde; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 116 KB

O-293 Follow-up of a phase I/II dose esc

O-293 Follow-up of a phase I/II dose escalation trial in non-small cell lung cancer using 3D conformal radiotherapy

✍ Belderbos, J.S.A.; De Jaeger, K.; Heemsbergen, W.D.; Seppenwoolde, Y.; Baas, P.; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB